Sunday, August 23, 2009

Codex Alimentarius

A scenario of drug dealers selling vitamins could become the norm soon, because of a set of “guidelines” used by the World Trade Organization (WTO) to resolve disputes.

These Guidelines are called the Codex Alimentarius (Food Cleanliness Codes). Because the WTO will use these guidelines to resolve disputes, countries which don’t accept the Codex, and make it law, will be penalized in international trade disputes for non compliance!

As most countries are either members of the WTO, or are trying to become members, this is one way of forcing the world to undemocratically submit to rules that will destroy the health of populations – but make billions in profit for the pharmaceutical cartel (which is of course owned by the world richest families, who are already trillionaires).

The section of the Codex that deals with nutritional supplements changes the classification of vitamins, minerals, phytonutrients, amino acids, and anything else necessary to sustain good health, from being foods, to being drugs. In other words, they would be controlled and regulated, and our access to these – essential ingredients for life – would only be via prescription from a doctor.

Why would the WTO do this? For the same reason that most things happen: money.

If you are taking nutritional supplements you are very unlikely to need or want drugs. That’s a real good reason for the pharma cartel to find a way to stop you from getting your vits.

On both sides of the Atlantic, politicians in office are voting for Codex Alimentarius. That means that elected representatives are stopping us from getting the essential nutrients we need for life.

These politicians are making it so that we will not be able to give anything close to a meaningful dose of vitamins in a health crisis – the likes of which will be upon us in a few short months. Even the terrestrial media is predicting the outbreak of Mexican flu pandemic this winter. and guess what? Roche has already made billions on pre-sales, of the symptom-suppressing Tamiflu – which heals nothing.

Did you know that Under Codex Alimentarius, any quantity of a vitamin larger than the RDA is considered potentially toxic and is illegal to sell? This, despite the fact that for decades many people have taken 100 times the RDA of Vitamin C (10 grams per day), even when they have been healthy – and a lot more if they’ve had a virus.

Food manufacturers want a very low RDA so they can say that their food contains 100% of the required amount of Vitamin C (and other vitamins), even though this is a lie. The pharma cartel wants to stop people from preventing and curing colds, flus, and other viral diseases with Vitamin C, so they can make billions of dollars every year selling cold and flu drugs that give only symptomatic relief – as Roche just did with Tamiflu. And they give no assurance that these will have any effect against Mexican flu!.

The aims of Codex Alimentarius are clearly defined: Statements on the curative effects of vitamins and other natural remedies will be banned and made a punishable offense. In the future, the distinction between a foodstuff and a medicine will be made by the pharma cartel itself, and not by governments. In other words, the pharma cartel will have the power to say vitamin C is a drug and can only be sold with a perscription!

Using this new legislative edict, the pharmaceutical industry will extend its own markets as it sees fit.

At present, the pharmaceutical industry in Germany has succeeded in classifying 500 milligrams of vitamin C, in pill form, as a medication requiring a prescription. If the pharmaceutical industry had its way, smaller amounts of vitamin C will be classified in the same manner.

The strategic aims of “Codex Alimentarius:

1. The distribution of health information concerning vitamins, amino acids, minerals and other natural products for the prevention and treatment of diseases will be banned globally.
2. The sale of vitamins and other natural products which exceed the guidelines of this Codex commission (which are arbitrary and far too low) will be prohibited globally.
3. Countries that fail to apply these laws will be punished by international economic sanctions.


Source: http://www.goodfitnesstips.com/2009/08/13/the-codex-alimentarius-and-the-wto/

Saturday, August 15, 2009

Pharma Medical Rep sales reporting on Mobile Phones

PRAvenue reports that MobiQuest, India based leading provider of Enterprise VAS, has changed the way pharmaceutical companies track and manage their on-field medical representatives. The company's product MobiSales for Pharmaceuticals industry has moved the highly complex, paper driven, non-accurate and cumbersome process of medical rep field activity reporting to a seamless real time system using basic mobile phones.

Moving from the current traditional paper based process that involves collecting field data, track daily visits, measure sales performance and do any sales forecasting to a mobile phone that every Sales Representative would carry. The idea behind the concept is- if the complete reporting application can be moved to his mobile phone, each transaction and his complete day activity can be updated from field in real time to central servers.

The product operates in two parts; the application is loaded on basic mobile phones of the sales force. The easy and intuitive GUI of the MobiSales product helps a basic worker to update / enter data on the phone. With fields and activity labels predefined, it is quite simple and fast. The data instantly gets updated in the central servers. The second part of the application is a full blown workflow and reporting system on the web to manage, track the field force and create forecasting and other relevant business reports.

Is it cost effective? Yes says Sabina Kamal, COO, MobiQuest "The best part is that the product does not require a huge capital investment in smart phones, it can run on basic Rs. 2000-3500 phones with GPRS connectivity. It is a highly cost effective and saves huge time. No paper, no data entry, no loss of data and above all it helps keep track of field force, avoids duplication, non-accurate data and delays in filling paper reports."

Indian Pharmaceuticals & Healthcare Industry- Latest Report

The India Pharmaceuticals and Healthcare Report has been researched at source and features the latest available data and forecasts to 2011 covering drugs and healthcare expenditure, the prescription, OTC and generics markets, and foreign trade; company rankings and competitive landscapes including multinational and national drugs companies; and analysis of latest industry news, trends and regulatory developments.

India Pharmaceuticals and Healthcare Report provides industry professionals, market investors and corporate and financial services analysts with independent forecasts and competitive intelligence on the Indian pharmaceutical and healthcare industry. We find this to be a concise view of the leading pharmaceutical companies in India. It allows us to focus on certain companies to determine if we need to initiate further research on their overall direction.

Independent 5-year pharmaceutical and healthcare industry forecasts for India.
Original pharmaceutical and healthcare market research and pharmaceutical and healthcare sector trend analysis for the Indian pharmaceutical and healthcare industry. Competitive intelligence, Indian pharmaceutical and healthcare company rankings and SWOT analyses on international and domestic pharmaceutical and healthcare companies in the Indian market.

Key Benefits of Report

* Benchmark It’s Independent 5-year Pharmaceutical and Healthcare Industry Forecasts on India to test other views – a key input for successful budgeting and strategic business planning in the Indian pharmaceutical and healthcare market.
* Target Business Opportunities & Risks in the Indian Pharmaceutical and Healthcare Sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in India.
* Exploit The Latest Competitive Indian Pharmaceutical and Healthcare Intelligence & company SWOTS on your competitors and peers through company rankings by sales, market share and ownership structure – includes multi-national and national companies in India.

Source : prminds
A copy of this report is available at : http://www.bharatbook.com/Market-Research-Reports/Pharmaceuticals-Healthcare-Report-India.html